Cargando…
Cardiovascular disease risk profiles in inflammatory joint disease entities
BACKGROUND: Patients with inflammatory joint diseases (IJD) have increased risk of cardiovascular disease (CVD). Our aim was to compare CVD risk profiles in patients with IJD, including rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) and evaluate the future r...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496163/ https://www.ncbi.nlm.nih.gov/pubmed/28673314 http://dx.doi.org/10.1186/s13075-017-1358-1 |
_version_ | 1783247915804786688 |
---|---|
author | Wibetoe, Grunde Ikdahl, Eirik Rollefstad, Silvia Olsen, Inge C. Bergsmark, Kjetil Kvien, Tore K. Salberg, Anne Soldal, Dag Magnar Bakland, Gunnstein Lexberg, Åse Fevang, Bjørg-Tilde Gulseth, Hans Christian Haugeberg, Glenn Semb, Anne Grete |
author_facet | Wibetoe, Grunde Ikdahl, Eirik Rollefstad, Silvia Olsen, Inge C. Bergsmark, Kjetil Kvien, Tore K. Salberg, Anne Soldal, Dag Magnar Bakland, Gunnstein Lexberg, Åse Fevang, Bjørg-Tilde Gulseth, Hans Christian Haugeberg, Glenn Semb, Anne Grete |
author_sort | Wibetoe, Grunde |
collection | PubMed |
description | BACKGROUND: Patients with inflammatory joint diseases (IJD) have increased risk of cardiovascular disease (CVD). Our aim was to compare CVD risk profiles in patients with IJD, including rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) and evaluate the future risk of CVD. METHODS: The prevalence and numbers of major CVD risk factors (CVD-RFs) (hypertension, elevated cholesterol, obesity, smoking, and diabetes mellitus) were estimated in patients with RA, axSpA and PsA. Relative and absolute risk of CVD according to Systematic Coronary Risk Evaluation (SCORE) was calculated. RESULTS: In total, 3791 patients were included. CVD was present in 274 patients (7.2%). Of those without established CVD; hypertension and elevated cholesterol were the most frequent CVD-RFs, occurring in 49.8% and 32.8% of patients. Patients with PsA were more often hypertensive and obese. Overall, 73.6% of patients had a minimum of one CVD-RF, which increased from 53.2% among patients aged 30 to <45 years, to 86.2% of patients aged 60 to ≤80 years. Most patients (93.5%) had low/moderate estimated risk of CVD according to SCORE. According to relative risk estimations, 35.2% and 24.7% of patients had two or three times risk or higher, respectively, compared to individuals with no CVD-RFs. CONCLUSIONS: In this nationwide Norwegian project, we have shown for the first time that prevalence and numbers of CVD-RFs were relatively comparable across the three major IJD entities. Furthermore, estimated absolute CVD risk was low, but the relative risk of CVD was markedly high in patients with IJD. Our findings indicate the need for CVD risk assessment in all patients with IJD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1358-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5496163 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54961632017-07-05 Cardiovascular disease risk profiles in inflammatory joint disease entities Wibetoe, Grunde Ikdahl, Eirik Rollefstad, Silvia Olsen, Inge C. Bergsmark, Kjetil Kvien, Tore K. Salberg, Anne Soldal, Dag Magnar Bakland, Gunnstein Lexberg, Åse Fevang, Bjørg-Tilde Gulseth, Hans Christian Haugeberg, Glenn Semb, Anne Grete Arthritis Res Ther Research Article BACKGROUND: Patients with inflammatory joint diseases (IJD) have increased risk of cardiovascular disease (CVD). Our aim was to compare CVD risk profiles in patients with IJD, including rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) and evaluate the future risk of CVD. METHODS: The prevalence and numbers of major CVD risk factors (CVD-RFs) (hypertension, elevated cholesterol, obesity, smoking, and diabetes mellitus) were estimated in patients with RA, axSpA and PsA. Relative and absolute risk of CVD according to Systematic Coronary Risk Evaluation (SCORE) was calculated. RESULTS: In total, 3791 patients were included. CVD was present in 274 patients (7.2%). Of those without established CVD; hypertension and elevated cholesterol were the most frequent CVD-RFs, occurring in 49.8% and 32.8% of patients. Patients with PsA were more often hypertensive and obese. Overall, 73.6% of patients had a minimum of one CVD-RF, which increased from 53.2% among patients aged 30 to <45 years, to 86.2% of patients aged 60 to ≤80 years. Most patients (93.5%) had low/moderate estimated risk of CVD according to SCORE. According to relative risk estimations, 35.2% and 24.7% of patients had two or three times risk or higher, respectively, compared to individuals with no CVD-RFs. CONCLUSIONS: In this nationwide Norwegian project, we have shown for the first time that prevalence and numbers of CVD-RFs were relatively comparable across the three major IJD entities. Furthermore, estimated absolute CVD risk was low, but the relative risk of CVD was markedly high in patients with IJD. Our findings indicate the need for CVD risk assessment in all patients with IJD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1358-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-07-03 2017 /pmc/articles/PMC5496163/ /pubmed/28673314 http://dx.doi.org/10.1186/s13075-017-1358-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Wibetoe, Grunde Ikdahl, Eirik Rollefstad, Silvia Olsen, Inge C. Bergsmark, Kjetil Kvien, Tore K. Salberg, Anne Soldal, Dag Magnar Bakland, Gunnstein Lexberg, Åse Fevang, Bjørg-Tilde Gulseth, Hans Christian Haugeberg, Glenn Semb, Anne Grete Cardiovascular disease risk profiles in inflammatory joint disease entities |
title | Cardiovascular disease risk profiles in inflammatory joint disease entities |
title_full | Cardiovascular disease risk profiles in inflammatory joint disease entities |
title_fullStr | Cardiovascular disease risk profiles in inflammatory joint disease entities |
title_full_unstemmed | Cardiovascular disease risk profiles in inflammatory joint disease entities |
title_short | Cardiovascular disease risk profiles in inflammatory joint disease entities |
title_sort | cardiovascular disease risk profiles in inflammatory joint disease entities |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496163/ https://www.ncbi.nlm.nih.gov/pubmed/28673314 http://dx.doi.org/10.1186/s13075-017-1358-1 |
work_keys_str_mv | AT wibetoegrunde cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities AT ikdahleirik cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities AT rollefstadsilvia cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities AT olseningec cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities AT bergsmarkkjetil cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities AT kvientorek cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities AT salberganne cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities AT soldaldagmagnar cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities AT baklandgunnstein cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities AT lexbergase cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities AT fevangbjørgtilde cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities AT gulsethhanschristian cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities AT haugebergglenn cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities AT sembannegrete cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities |